Nexalis Therapeutics Limited (ASX:NX1)
0.0080
0.00 (0.00%)
At close: Nov 13, 2026
| Market Cap | 2.02M -68.0% |
| Revenue (ttm) | 1.07M +28.0% |
| Net Income | -2.06M |
| EPS | -0.01 |
| Shares Out | 253.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,080,550 |
| Open | 0.0080 |
| Previous Close | 0.0080 |
| Day's Range | 0.0080 - 0.0080 |
| 52-Week Range | 0.0070 - 0.0360 |
| Beta | -0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 1, 2026 |